Halo Bio is a brand that specializes in RNAi technology, offering a comprehensive platform for the development of biopharmaceuticals. Their platform consists of three key technologies: RNAi API, RNA CORE, and PARTICLE SHELLS. The RNAi API, known as MV-RNA, is a patented RNAi trigger that is capable of multi-gene suppression.

It holds great promise in the treatment of various human diseases, either alone or in nanoparticle form. The RNA CORE, built from MV-RNA sequences, serves as both the active ingredient and the drug architecture for precision medicine. It reliably forms ideal-sized RNA nanoparticles that hold potential in the treatment of cancer and infectious diseases.

When combined with RNA CORE, PARTICLE SHELLS offer a breakthrough in the delivery of biopharmaceuticals into cells, providing a first-of-its-kind methodology that is programmable for each target tissue. Halo Bio's innovative HALO PARTICLE™ technology overcomes the delivery challenges of RNAi-based biopharmaceuticals, allowing for the rapid development of treatments for various human diseases. Their integrated RNA CORE/SHELL nanoparticle offers specific gene silencing and programmable targeting of disease organs.

With this patented and sustainable biopharmaceutical platform, Halo Bio collaborates with industry partners to develop novel treatments. In addition, Halo Bio is also focusing on AmpliVIR RNA, an RNA-inspired treatment for viral infections like nCOV SARS-2. This rapid-response treatment aims to prevent significant loss of life and economic instability.

By targeting intercellular coronavirus infections, AmpliVIR has the potential to neutralize infections without the use of harmful small molecules. This scalable nano biotechnology can be formulated for effective delivery to infected tissue. Halo Bio welcomes researchers and biotechnology companies to explore collaborations and licensing opportunities for their innovative technologies.

Join them in their mission to revolutionize biopharmaceutical development and advance treatments for human diseases